8-K
Current Report
Denali Therapeutics Inc. Filed Acc 0001714899-26-000081
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading dnli-20260612.htm…